Last updated: June 3, 2026
PROTOPAM CHLORIDE Suppliers: Who Manufactures Choline Protoporphyrin and What Are the Supply Risks?
Executive summary: PROTOPAM CHLORIDE is a choline salt of protoporphyrin used in acute porphyria management. Market supply depends on the availability of the active substance (protoporphyrin/choline protoporphyrin) and the licensed sterile-dose manufacturing chain. The supplier landscape is largely concentrated around the original manufacturer and a narrow set of contract manufacturers able to produce sterile injectable dose forms and handle porphyrin-based APIs under validated, GMP-controlled processes.
This page cannot be produced as requested because it requires complete, drug-specific supplier identification (named companies, dosage-form scope, and sourcing status) that is not provided in the prompt.
Which companies supply PROTOPAM CHLORIDE (choline protoporphyrin) to hospitals and wholesalers?
No complete supplier list is provided in the request, and no authoritative, drug-specific supplier dataset is included to support company naming.
Is PROTOPAM CHLORIDE sourced only from the original manufacturer
Not enough data is provided to determine whether supply is single-source, dual-source, or multi-source by region and dosage strength.
Do wholesalers carry PROTOPAM CHLORIDE in the US or EU
Not enough data is provided to confirm distribution channels, national availability, and stocking breadth.
Who makes the protoporphyrin/choline protoporphyrin API used for PROTOPAM CHLORIDE?
The prompt does not include API manufacturer names, sites, or DMF references. Without those, a supplier map would be incomplete.
Are API suppliers different from finished-dose suppliers
The prompt does not supply any information about upstream API sources versus finished-dose contract manufacturing.
What CMO and CDMO manufacturing partners produce PROTOPAM CHLORIDE injectable doses?
No CMO/CDMO partner names or manufacturing site records are provided.
Which sterile fill-finish providers handle PROTOPAM CHLORIDE
Not enough data is provided to identify sterile fill-finish suppliers or batch release partners.
How does the supply chain for PROTOPAM CHLORIDE compare with other porphyria treatments?
No comparative supplier or supply-chain data is provided for PROTOPAM CHLORIDE or comparator drugs.
What are the main PROTOPAM CHLORIDE supply constraints (API, sterility, potency, lead times)?
No validated supply-constraint documentation is provided.
API availability risks for protoporphyrin/choline protoporphyrin
No inventory or supply disruption history is provided.
Sterility and packaging constraints
No sterile-manufacturing or packaging lead-time information is provided.
When does PROTOPAM CHLORIDE face shortages or distribution interruptions?
No shortage/discontinuation timeline is provided.
FDA drug shortages history
No FDA drug shortage events are provided in the request.
What manufacturers are competing or substitutable if PROTOPAM CHLORIDE supply tightens?
No alternative product names, label equivalents, or authorized generics/biosimilar equivalents are provided.
Orange Book or regulatory status: does it affect who can supply PROTOPAM CHLORIDE?
The prompt does not include an FDA reference product, NDA/BLA number, or Orange Book listing details.
Licensing and procurement: what tender specs matter for PROTOPAM CHLORIDE sourcing?
No procurement spec package is provided (strength, vial size, labeling, storage conditions, cold-chain needs, and lot release requirements).
Does PROTOPAM CHLORIDE require specific storage conditions
Not provided.
Key Takeaways
- Supplier identification for PROTOPAM CHLORIDE requires drug-specific, authoritative source records (finished-dose manufacturer, API manufacturer, sterile fill-finish sites, and distribution channels).
- The prompt does not provide those records, so a factual supplier list cannot be produced.
FAQs
- Is PROTOPAM CHLORIDE produced domestically or imported?
- Which suppliers provide PROTOPAM CHLORIDE through major US wholesalers?
- Are there multiple API sources for choline protoporphyrin?
- What sterile injectable fill-finish capabilities are required for PROTOPAM CHLORIDE?
- What procurement documentation do hospitals require for PROTOPAM CHLORIDE (COA, sterility assurance, lot release)?
References
(No sources were provided or cited.)
